Basic Information
Basic information for SNHG14-295-28aa-3
Peptide Name SNHG14-295-28aa-3
Genome Position chr15:25239650-25239733[+]
Species Human
Peptide Sequence MLTLEEDLCRAPRPQASVHQPGAQLPVR
Peptide Length 28
Unique No (SNHG14-203-28aa-3,SNHG14-225-28aa-3,SNHG14-226-28aa-1,SNHG14-228-28aa-7,SNHG14-229-28aa-2,SNHG14-243-28aa-1,SNHG14-244-28aa-5,SNHG14-245-28aa-1,SNHG14-266-28aa-1,SNHG14-267-28aa-1,SNHG14-273-28aa-1,SNHG14-284-28aa-1,SNHG14-285-28aa-3,SNHG14-292-28aa-1,SNHG14-294-28aa-3,SNHG14-317-28aa-1,SNHG14-320-28aa-1,SNHG14-326-28aa-1,SNHG14-327-28aa-1,SNHG14-328-28aa-1,SNHG14-329-28aa-5,SNHG14-331-28aa-6)
Grand Average of Hydropathicity -0.45
Relative Molecular Mass 3600.03
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000665397;SNHG14-295
Transcript Length 6507
Coding Ability 0.491
DNA Sequence Corresponding to Peptide ATGCTGACCCTGGAGGAAGACTTGTGTCGGGCCCCCAGGCCCCAGGCCAGTGTCCATCAGCCAGGTGCTCAGCTCCCAGTGCGC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :